Trial
NCT03262116
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
Boston University
Condition
Type 1 Diabetes Mellitus
Intervention
Humalog
Why stopped
Devices are not available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-09